Author

Andrew Patterson

The Wistar InstituteORCID 0000-0002-2678-8006Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Approach:experimental assay· 2 Organism:human· 2 Approach:statistical model· 2 Research Focus:benchmarking· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:clustering· 1

Frequent Co-Authors

Noam AuslanderiD· 2 shared Anastasia Lucas· 1 shared Arjun RajiD· 1 shared Avi SrivastavaiD· 1 shared Bryant Duong· 1 shared Cong QiiD· 1 shared Dave SB Hoon· 1 shared Dylan F. FingermaniD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioinformatics

Noam AuslanderORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BioinformaticsbioRxivPreprintMay 21, 2026

A phylogeny-guided framework for decoding mechanisms of human endogenous retrovirus regulation in health and disease

Andrew Patterson, Bryant Duong, Leena Yoon…·Noam Auslander

ERVmancer is a phylogeny-informed method that resolves read-mapping ambiguity for HERVs, outperforming existing approaches and revealing new biology in breast cancer.

DOI 10.64898/2026.05.19.726217

humanwhole-genome sequencing

𝕏 PostBluesky

Cancer BiologyMolecular CancerPeer-reviewedMar 3, 2026

Clonal dynamics shaped by diverse drug-tolerant persister states in melanoma resistance

Haiyin Li, Yeqing Chen, Jessica Kaster…·Meenhard Herlyn

This study identifies drug-tolerant persister states in melanoma using MeRLin, showing their role in resistance and tumor recurrence.

4 citationstop 2%

humanscRNA-seq

𝕏 PostBluesky